Cargando…
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway
BACKGROUND: Fibro-adipose vascular anomaly (FAVA) is a new entity of vascular anomalies with somatic and mosaic gain-of-function mutations of the phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA). PIK3CA mutation excessively activates mammalian target of rapamycin (mTO...
Autores principales: | Hori, Yumiko, Hirose, Katsutoshi, Aramaki-Hattori, Noriko, Suzuki, Sachi, Nakayama, Robert, Inoue, Masanori, Matsui, Takahiro, Kohara, Masaharu, Toyosawa, Satoru, Morii, Eiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382067/ https://www.ncbi.nlm.nih.gov/pubmed/32711543 http://dx.doi.org/10.1186/s13000-020-01004-z |
Ejemplares similares
-
Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA)
por: Hori, Yumiko, et al.
Publicado: (2022) -
PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibfibroipose vascular anomaly (FAVA)
por: Hori, Yumiko, et al.
Publicado: (2022) -
Management of Fibro-adipose Vascular Anomalies (FAVA) in Paediatric Practice
por: Lipede, C, et al.
Publicado: (2021) -
Fibro-adipose vascular anomaly (FAVA) - diagnosis, staging and management
por: Wang, Huaijie, et al.
Publicado: (2023) -
Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic PIK3CA Mutation
por: Driskill, Jordan H., et al.
Publicado: (2022)